Literature DB >> 3751956

Sterol excretion and cholesterol absorption in diabetics and nondiabetics with and without hyperlipidemia.

E R Briones, D L Steiger, P J Palumbo, W M O'Fallon, A L Langworthy, B R Zimmerman, B A Kottke.   

Abstract

Fecal neutral and acidic sterols and cholesterol absorption were measured in 12 normal control subjects, 40 diabetic subjects with and without hyperlipidemia, and 27 subjects with hyperlipidemia but without diabetes mellitus. All subjects were on a low-cholesterol diet (less than 300 mg cholesterol/day). Fecal excretion of neutral and acidic sterols was increased in patients with hypertriglyceridemia and was more marked in diabetic patients with hypertriglyceridemia. Cholesterol absorption was decreased in diabetic patients with hypertriglyceridemia. Otherwise, there were no significant differences in sterol excretion or cholesterol absorption in diabetic and nondiabetic subjects compared with control groups with similar lipid levels. The best predictors of fecal neutral- and acidic-sterol excretion and of estimated cholesterol synthesis were very low [corrected]-density lipoprotein triglycerides and high-density lipoprotein cholesterol. Correction of hyperlipidemia may be beneficial in decreasing cholesterol synthesis and, thereby, in decreasing the risk of atherogenesis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3751956     DOI: 10.1093/ajcn/44.3.353

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  8 in total

1.  Insulin sensitivity regulates cholesterol metabolism to a greater extent than obesity: lessons from the METSIM Study.

Authors:  Helena Gylling; Maarit Hallikainen; Jussi Pihlajamäki; Piia Simonen; Johanna Kuusisto; Markku Laakso; Tatu A Miettinen
Journal:  J Lipid Res       Date:  2010-05-01       Impact factor: 5.922

2.  A study measuring the effect of high serum triglyceride and cholesterol on glucose elevation in human serum.

Authors:  Mohammed Wael Daboul
Journal:  Oman Med J       Date:  2011-03

Review 3.  Cholesterol metabolism and therapeutic targets: rationale for targeting multiple metabolic pathways.

Authors:  Stephen D Turley
Journal:  Clin Cardiol       Date:  2004-06       Impact factor: 2.882

4.  Alterations in cholesterol absorption/synthesis markers characterize Framingham offspring study participants with CHD.

Authors:  Nirupa R Matthan; Michael Pencina; Jane M LaRocque; Paul F Jacques; Ralph B D'Agostino; Ernst J Schaefer; Alice H Lichtenstein
Journal:  J Lipid Res       Date:  2009-05-12       Impact factor: 5.922

5.  Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolaemic NIDDM patients before and during sitostanol ester-margarine treatment.

Authors:  H Gylling; T A Miettinen
Journal:  Diabetologia       Date:  1994-08       Impact factor: 10.122

6.  Sex-specific differences in the predictive value of cholesterol homeostasis markers and 10-year cardiovascular disease event rate in Framingham Offspring Study participants.

Authors:  Nirupa R Matthan; Lei Zhu; Michael Pencina; Ralph B D'Agostino; Ernst J Schaefer; Alice H Lichtenstein
Journal:  J Am Heart Assoc       Date:  2013-02-19       Impact factor: 5.501

7.  Non-cholesterol sterol levels predict hyperglycemia and conversion to type 2 diabetes in Finnish men.

Authors:  Henna Cederberg; Helena Gylling; Tatu A Miettinen; Jussi Paananen; Jagadish Vangipurapu; Jussi Pihlajamäki; Teemu Kuulasmaa; Alena Stančáková; Ulf Smith; Johanna Kuusisto; Markku Laakso
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

Review 8.  Implications of the obesity epidemic for lipid-lowering therapy: non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target.

Authors:  Michel R Hoenig
Journal:  Vasc Health Risk Manag       Date:  2008
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.